A phase II randomized trial of sodium oligomannate in Alzheimer’s dementia
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A phase II randomized trial of sodium oligomannate in Alzheimer’s dementia
Authors
Keywords
-
Journal
Alzheimers Research & Therapy
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-14
DOI
10.1186/s13195-020-00678-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression
- (2019) Xinyi Wang et al. CELL RESEARCH
- Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis
- (2018) Chen-Chen Tan et al. JOURNAL OF ALZHEIMERS DISEASE
- Has the rising placebo response impacted antidepressant clinical trial outcome? Data from the US Food and Drug Administration 1987-2013
- (2017) Arif Khan et al. World Psychiatry
- Moving beyond anti-amyloid therapy for the prevention and treatment of Alzheimer’s disease
- (2014) Michael A Castello et al. BMC Neurology
- Amyloid-directed monoclonal antibodies for the treatment of Alzheimer’s disease: the point of no return?
- (2014) Francesco Panza et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- An update on drug treatment options of Alzheimer's disease
- (2014) Michael Allgaier Frontiers in Bioscience-Landmark
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synthesis and bioassay of β-(1,4)-D-mannans as potential agents against Alzheimer's disease
- (2013) Ru-wei Jiang et al. ACTA PHARMACOLOGICA SINICA
- Investigation of Influencing Factors on Higher Placebo Response in East Asian Versus Western Clinical Trials for Partial Epilepsy: A Meta-Analysis
- (2013) Yosuke Tachibana et al. CLINICAL DRUG INVESTIGATION
- Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990–2010: a systematic review and analysis
- (2013) Kit Yee Chan et al. LANCET
- Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: Implications for diagnostic and therapeutic strategies
- (2013) Zhichun Chen et al. PROGRESS IN NEUROBIOLOGY
- Reliability and validity of the Chinese version of the neuropsychiatric inventory in mainland China
- (2011) Tao Wang et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Amino Acid Position-specific Contributions to Amyloid β-Protein Oligomerization
- (2009) Samir K. Maji et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started